BCDRF
Banco Santander, S.A.
$12.60
+0.24%
No data for this timeframe.
Vol
SEC Reports10
Recent Activity
Jun 4, 2026
SEC
Banco Santander reported weekly buyback transactions from May 28 to June 3, 2026, repurchasing 12,765,369 shares. Cumula
6-K — Impact 4/10
Jun 3, 2026
SEC
Banco Santander filed a 6-K attaching the final executed indenture, underwriting agreement, and first supplemental inden
6-K — Impact 4/10
May 28, 2026
SEC
Banco Santander is issuing $1.5 billion of 7.250% perpetual AT1 contingent convertible preferred securities (CoCos). Net
424B5 — Impact 4/10
Analyst Ratings
5Strong Buy
17Buy
6Hold
1Sell
0Strong Sell
Historical Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Nov 8, 2023 | JP Morgan | MAINTAIN | Neutral → Neutral |
Latest Reports
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
10 SEC filing reports analyzed. Sentiment: 1 bullish, 0 bearish, 1 mixed, 8 neutral. Avg impact: 4.8/10.
NEUTRAL
6-K
4/10
Banco Santander reported weekly buyback transactions from May 28 to June 3, 2026, repurchasing 12,76
Jun 4, 2026
NEUTRAL
6-K
4/10
Banco Santander filed a 6-K attaching the final executed indenture, underwriting agreement, and firs
Jun 3, 2026
NEUTRAL
424B5
4/10
Banco Santander is issuing $1.5 billion of 7.250% perpetual AT1 contingent convertible preferred sec
May 28, 2026
NEUTRAL
424B5, 6-K
4/10
Banco Santander (BCDRF) filed a preliminary prospectus supplement for a new issue of Non-Step-Up Non
May 27, 2026
NEUTRAL
6-K
5/10
Banco Santander announced a tender offer to purchase up to $850 million of its outstanding 4.750% No
May 27, 2026
NEUTRAL
425
5/10
Banco Santander temporarily suspended its share buyback program from April 24 to May 26, 2026, due t
Apr 23, 2026
MIXED
EFFECT, 6-K
7/10
Banco Santander's registration statement on Form F-4 for its acquisition of Webster Financial Corpor
Apr 23, 2026
NEUTRAL
424B5
4/10
Banco Santander is issuing four series of senior non-preferred notes totaling an undisclosed amount,
Apr 8, 2026
NEUTRAL
6-K
4/10
Banco Santander reported share repurchases totaling 31,955,792 ordinary shares for €2.71 billion bet
Apr 8, 2026
BULLISH
425
7/10
Banco Santander is advancing integration planning for its acquisition of Webster Financial Corporati
Apr 7, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution (last covering-analyst action Nov 2023): 76% buy across 29 analysts — 5 strong buy, 17 buy, 6 hold, 1 sell, 0 strong sell. No current recommendation available.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $16.0B | 3.1% | — |
| Next Q 2026-09-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $16.5B | 8.3% | — |
| Current FY 2026-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $63.0B | 1.0% | — |
| Next FY 2027-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $67.9B | 7.7% | — |
1 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 0 initiations.
Historical Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Nov 8, 2023 | JP Morgan | MAINTAIN | Neutral | Neutral |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 5 | 17 | 6 | 1 | 0 | 76% | |
| May 1, 2026 | 5 | 17 | 6 | 1 | 0 | 76% | |
| Apr 1, 2026 | 5 | 17 | 6 | 1 | 0 | 76% | |
| Mar 1, 2026 | 5 | 16 | 7 | 1 | 0 | 72% | |
| Feb 1, 2026 | 6 | 17 | 5 | 0 | 1 | 79% | |
| Jan 1, 2026 | 5 | 17 | 7 | 0 | 0 | 76% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.